Hwail Pharm. Co., Ltd.

- Introduction
In 1974, Hwail Pharmaceutical company started its business as a domestic wholes
aler of pharmaceutical raw materials. In 1987, our business was expanded by establishing the manufacturing facilities of raw pharmaceuticals located in the Hyangnam Pharmaceutical Complex. In 1998, the R & D center was established to accommodate our aim to strengthen the R&D capability and domestic production of raw pharmaceuticals that have been supplied by import.
Hwail P
harm specializes in the development of new process, which can be designed to ensure the on-infringement of patents through the application of alternative synthetic procedure and supplies the best quality products for the customers under the strict quality & manufacturing control system.
Currently, we stock over a thousand of pharmaceutical raw materials and food additives ei
ther from imports or synthesis from our factory.
Our aim is to provide our valuable customers ?The best quality products?
by maintaining the highest standard of quality control as well as investing consistently on Our aim is to provide our valuable customers ?The best quality products? by maintaining the highest standard of quality control as well as investing consistently on R & D.
- History
1974 : Established the domestic wholesaler of pharmaceutical raw materials.
1987 : Completed
the pharmaceutical raw materials manufacturing plant in Hyangnam Pharmaceutical Complex.
1998 : Established the R & D Cente
r
2001 : Gain the GSP Certification from Korea FDA
2002 : Gained the GMP Certification from Korea FDA
2002 : Regist
ered with KOSDAQ (Korea Securities Dealers Association Automated Quotations)
2005 : Completed the second production plant
for new products
- Product list
Aceclofenac
Acemetacin
Alibendol
Ambroxol HCl
Coenzyme Q10 (Ubidecare
none)
Dichloralphenazone
Erdosteine
Felbinac
Gallamine Triethiodide
Levosulpiride
Oxatomide
Talnifl
umate
Terazocin HCl. 2H2O
Tiropramide HCl
Triflusal